Back to top
   Call Me Free Send SMS Send Inquiry
+918037402610
Pharmaceutical Ingredients

Pharmaceutical Ingredients

50 Onwards USD ($)/Kilograms

Product Details:

  • Molecular Weight 307.31 Grams (g)
  • Molecular Formula C₁₆H₁₃N₅O₂
  • Place of Origin India
  • Melting Point 188-193°C
  • Other Names (2-Methyl-5-nitrophenyl)[4-(pyridin-3-yl)pyrimidin-2-yl]amine; 2-Methyl-5-nitro-N-[4-(pyridin-3-yl)pyrimidin-2-yl]benzenamine; N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine;
  • CAS No 152460-09-8
  • Type Other
  • Supply Ability : 100 Gram Per Month
  • Click to view more
X

Price And Quantity

  • 50 Gram
  • 50 Onwards USD ($)/Kilograms

Product Specifications

  • 188-193°C
  • 152460-09-8
  • (2-Methyl-5-nitrophenyl)[4-(pyridin-3-yl)pyrimidin-2-yl]amine; 2-Methyl-5-nitro-N-[4-(pyridin-3-yl)pyrimidin-2-yl]benzenamine; N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine;
  • Powder
  • India
  • 307.31 Grams (g)
  • C₁₆H₁₃N₅O₂
  • Other
  • Yellow
  • Aromatics, Nucleotides, Bases & Related Reagents
  • No Smell

Trade Information

  • 100 Gram Per Month
  • 1 Months
  • Within a certain price range free samples are available

Product Description

Pharmaceutical Ingredients serves as intermediate in formulation of anti-cancer drugs that are prescribed for treatment of chronic myelogenous leukemia & acute lymphocytic leukemia. They are highly effective in nature and assure targeted mode of action. These ingredients show molecular formula C30H35N7O4S with molar mass of 589.715 g/mol. They are said to work by binding to TK active site and inhibits its activity. Pharmaceutical Ingredients shows bioavailability of about 98% with protein binding ability of 95% and get metabolized in liver with help of CYP3A4. They belong to drug class of antineoplastic agents.

N-(2-Methyl-5-nitrophenyl)-4-(pyridin3-yl)pyrimidin-2-amine,
IMATINIB MESYLATE - Intermediate


CHAKRACHEMLIFESCIENCESPVT.LTD.

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.